Chao Hung Kao
Nurse Practitioner · la Palma, CANPI 1629303698
Payments from drug & device makers
Across 283 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$639
- AbbVie$635
- Novartis$419
- Lilly USA, LLC$386
- AstraZeneca$304
- Merck$301
- plus $3K from 30 others
What the payments were for
- Food & beverage$5,53898%
- Education$1182%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 62 | $639 |
| AbbVie | 25 | $635 |
| Novartis | 27 | $419 |
| Lilly USA, LLC | 24 | $386 |
| AstraZeneca | 13 | $304 |
| Merck | 12 | $301 |
| Amgen | 15 | $263 |
| Johnson & Johnson | 3 | $250 |
| GSK | 8 | $230 |
| Pfizer | 11 | $205 |
| Biohaven Pharmaceuticals, Inc. | 3 | $199 |
| Radius Health, Inc. | 10 | $184 |
| Sanofi | 3 | $174 |
| Boehringer Ingelheim | 11 | $163 |
| Regeneron Healthcare Solutions, Inc. | 2 | $154 |
| Bayer | 8 | $140 |
| Ardelyx, Inc. | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $124 |
| Astellas Pharma US Inc | 2 | $116 |
| Dexcom, Inc. | 1 | $101 |
| Idorsia Pharmaceuticals US Inc | 6 | $97 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $80 |
| Amarin Pharma, Inc. | 3 | $60 |
| Sanofi Pasteur Inc. | 3 | $54 |
| Biogen | 2 | $42 |
| Alk-abello, Inc | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Exeltis, USA Inc. | 1 | $24 |
| Lexicon Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Organon | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$245
- XARELTO$225
- VERQUVO$212
- IBSRELA$125
- AIRSUPRA$125
- NURTEC ODT$125
- Wegovy$122
- VRAYLAR$121
- UBRELVY$105
- AREXVY$104
- DEXCOM G7 GSS (161)$101
- DEXCOM STELO GLUCOSE BIOSENSOR$101
How this compares
$5,656 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 39 | $64,459 |
| JardianceEmpagliflozin | 52 | $57,862 |
| RybelsusSemaglutide | 30 | $40,663 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 16 | $36,073 |
| OzempicSemaglutide | 18 | $29,475 |
| KerendiaFinerenone | 27 | $19,540 |
| VemlidyTenofovir Alafenamide | 11 | $15,602 |
| EliquisApixaban | 24 | $13,810 |
| XareltoRivaroxaban | 12 | $13,720 |
| MyrbetriqMirabegron | 25 | $13,057 |
| FarxigaDapagliflozin Propanediol | 18 | $12,013 |
| Repatha SureclickEvolocumab | 13 | $10,065 |
| VascepaIcosapent Ethyl | 18 | $9,155 |
| Xigduo XrDapaglifloz Propaned/Metformin | 15 | $8,806 |
| LinzessLinaclotide | 12 | $6,191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia, Evenity (2 Syringes) | $263 | $100,53255 claims |
| Novo NordiskRybelsus, Ozempic | $639 | $70,13848 claims |
| Boehringer IngelheimJardiance | $163 | $57,86252 claims |
| BayerKerendia | $140 | $19,54027 claims |
| PfizerEliquis | $205 | $13,81024 claims |
| Johnson & JohnsonXarelto | $250 | $13,72012 claims |
| Astellas Pharma US IncMyrbetriq | $116 | $13,05725 claims |
| AstraZenecaFarxiga | $304 | $12,01318 claims |
| AbbVieLinzess | $635 | $6,19112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in la Palma
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$899K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.